Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen

Clinical trial NCT06251947 · RECRUITING

Trial details

NCT number: NCT06251947
Sponsor: Shandong University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Cervical Cancer

Start date: 2024-04-15
Primary completion: 2026-06-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.